What does Irx do?
iRX is a biotechnology company dedicated to developing innovative therapies for various diseases. It focuses on leveraging advanced research to create effective treatment solutions, particularly in the fields of oncology and rare diseases. iRX aims to improve patient outcomes through its cutting-edge drug development programs.
- Signals
-
ProfitableProfitable € 800K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 3.80MStrong equity provides a buffer against setbacks.
Low riskLow risk 93.9%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 13.04A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 805KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 1.04MPositive EBITDA: operating activities are profitable.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
1.05M
|
€
1.01M
|
€
735K
|
€
1.01M
|
|
|
€
1.04M
|
€
1.00M
|
€
735K
|
€
1.01M
|
|
|
€
800K
|
€
780K
|
€
447K
|
€
664K
|
|
|
€
3.80M
|
€
3.23M
|
€
2.60M
|
€
2.15M
|
|
|
93.87%
|
95.68%
|
94.92%
|
95.96%
|
|
|
€
248K
|
€
146K
|
€
139K
|
€
90K
|
|
|
€
2.66M
|
€
2.05M
|
€
2.05M
|
€
1.53M
|
Frequently asked questions
Answers to the most common questions about Irx, based on official government data and the filed annual accounts.
What is the VAT number of Irx?
The VAT number of Irx is BE0700.354.153.
When was Irx established?
Irx was founded in 24-07-2018.
What is the official address of Irx?
The official address of Irx is Louizastraat 8 Antwerpen 2000.
What is the legal form of Irx?
The juridical form of Irx is Private limited company (BV/SRL).
What is the annual revenue of Irx?
The 2025 accounts of Irx do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Irx do?
iRX is a biotechnology company dedicated to developing innovative therapies for various diseases. It focuses on leveraging advanced research to create effective treatment solutions, particularly in the fields of oncology and rare diseases. iRX aims to improve patient outcomes through its cutting-edge drug development programs.
Is Irx a reliable company?
Irx is a registered Rechtspersoon with company number 0700.354.153 and can be verified through the official CBE database.
What is the credit limit of Irx?
The estimated credit limit of Irx is €1,312,848.
Is Irx still active?
Irx currently has the status "Normal situation" and is active.